Dear Mr. Berko: Recently, I’ve been hearing the term “labor force participation rate” on most of the news shows. Could you please explain what this term means in simple-to-understand English?
Hate Risk? You’ll Love These 3 Stocks
These three stocks are about as safe as it gets. You’re likely aware that stocks tend to be more volatile than other asset classes. That simple fact keeps many from putting
The Most Important Lesson From Wells Fargo’s Giant Debacle
Wells Fargo is guilty of the same type of behavior that got its less-respected peers, Bank of America and Citigroup, into so much trouble eight years ago — that is,
Why Is Apple Trying to Buy This Tiny British Automaker?
A report that Apple is in talks to buy a British sports- and racing-car maker McLaren Technology Group raises questions, starting with this: Why? Apple (NASDAQ:AAPL) has approached McLaren Technology Group, a
The Second Computing Revolution
The IBM Personal Computer debuted 35 years ago, igniting a new way of computing that empowered individuals and forever changed the way we work and play. The pioneers knew they
Flow: The Ultimate State of Creativity and Innovation
As I write this, summer is almost over – at least in Florida for those of us with kids. The calendar says “dog days of August,” the thermometer says “hot,”
An Orwellian Executive Order
Dear Mr. Berko: Is there a group called the Plunge Protection Team that is part of the Federal Reserve and is supposed to prevent stock crashes and allow the administration
Hate Checking Your Portfolio? Try These 2 Stocks
If your portfolio is stressing you out, these two stocks could take a load off your mind. I have good news for those of you who hate checking your portfolio
Hold Hilton?
Dear Mr. Berko: I bought 1,000 shares of Hilton Worldwide at $29 in March 2015, and the stock’s performance has been a bummer. How will the increasing minimum wage in
Is This New Market the Biggest Investment Idea of the Decade?
The market for biosimilar medicine could skyrocket to $20 billion in the coming years. Over $100 billion in annual sales for top-selling biologic medicines will soon be up for grabs,